Aer Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-19.
Aer Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 19, 2026. The filing reports $3M sold. Its industry group is Biotechnology. It names Thomas Mathers (Executive Officer, Director), John Fahy (Director), Evan Caplan (Director) (SEC Form D, August 19, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Aer Therapeutics, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Aer Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Aer Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Aer Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when Aer Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Aer Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Aer Therapeutics, Inc. →Get the full cited report on Aer Therapeutics, Inc.
What the filing shows about Aer Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Aer Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Aer Therapeutics, Inc.'s address as 8 Davis Dr, Research Triangle Park, NC 27709.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Aer Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Aer Therapeutics, Inc. is a registered filer with the SEC (CIK 1959576) and has filed since 2022-12-22. 3 filings are on record, the latest on 2026-08-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Aer Therapeutics, Inc.'s Form D of 2026-08-19 names Thomas Mathers, John Fahy, Evan Caplan and 2 more as its officers, directors or promoters.
Its new offerings report $23.88M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $3M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Proceeds will be used for working capital, which may include normal compensation to executive officers.
Checked away from the filing. What is below does not come from the record on sec.gov.
AER Therapeutics is developing mucolytic treatments that target mucus plugs in COPD and asthma to improve lung function and quality of life.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Thomas Mathers is named as Executive Officer and Director on the Form D that Aer Therapeutics, Inc. filed with the SEC on 19 August 2026, one of 5 people that filing names.
John Fahy is named as Director on the Form D that Aer Therapeutics, Inc. filed with the SEC on 19 August 2026, one of 5 people that filing names.
Evan Caplan is named as Director on the Form D that Aer Therapeutics, Inc. filed with the SEC on 19 August 2026, one of 5 people that filing names.
Tim Shannon is named as Director on the Form D that Aer Therapeutics, Inc. filed with the SEC on 19 August 2026, one of 5 people that filing names.
Christy Shaffer is named as Director on the Form D that Aer Therapeutics, Inc. filed with the SEC on 19 August 2026, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2026-08-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Aer Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Aer Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aer Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Aer Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Aer Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (aertherapeutics.com).
Each opens in a new tab, filled in for Aer Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-08-17 · Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/aer-therapeutics-inc-form-d-26000001